ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

Radboud University Medical Center at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Radboud University Medical Center takes part in 7 sessions at ESMO 2026 in Madrid. Its work spans lung and prostate cancer, biomarkers, and treatment response. It examines blood-based tumor DNA for genetic profiling and breath analysis to predict response in advanced lung cancer.

OrganizationESMO 2026 Attendance
Cancer centre & hospital
University medical centre in Nijmegen, Netherlands, combining a university hospital with the medical faculty of Radboud University.
Abstract
Fri Oct 23
14:07–14:12
2220RO - Plasma ctDNA as standalone or adjunct to tumour tissue for HRR and PI3K/AKT genotyping in mCRPC: PROMPT (NCT04746300)
Rapid oral: Genitourinary tumours, prostate, penile and testis
Genitourinary cancersGastrointestinal cancers
Poster
Fri Oct 23
15:15–16:00
Poster
Fri Oct 23
15:15–16:00
Talk
Fri Oct 23
16:35–16:55
Emerging immune-based therapies
Emerging therapeutic strategies in advanced prostate cancer
Genitourinary cancers
Talk
Sun Oct 25
10:45–10:55
CN12 - Cancer treatment and survival in adults with intellectual disability: A nationwide population based cohort study
Equitable health care of underserved population
Nursing & supportive care
Poster
Sun Oct 25
12:00–12:45
Poster
Sun Oct 25
12:00–12:45

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Radboud University Medical Center

Tell us what you sell and we’ll find the people at Radboud University Medical Center most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction